scholarly journals A Phase I/III, multicenter, open-label trial of talimogene laherparepvec (T-VEC) in combination with pembrolizumab for the treatment of unresected, stage IIIb-IV melanoma (MASTERKEY-265)

2015 ◽  
Vol 3 (S2) ◽  
Author(s):  
Georgina V Long ◽  
Reinhard Dummer ◽  
Antoni Ribas ◽  
Igor Puzanov ◽  
Olivier Michielin ◽  
...  
Keyword(s):  
Phase I ◽  
Stage Iiib ◽  
Talimogene Laherparepvec ◽  
Open Label ◽  
Open Label Trial

scholarly journals A Phase I, multicenter, open-label trial to evaluate the safety of talimogene laherparepvec (T-VEC) injected into liver tumors

2015 ◽  
Vol 3 (S2) ◽  
Author(s):  
J Randolph Hecht ◽  
Steven Raman ◽  
Daniel Y Sze ◽  
A Craig Lockhart ◽  
Rebecca A Moss ◽  
...  
Keyword(s):  
Phase I ◽  
Liver Tumors ◽  
Talimogene Laherparepvec ◽  
Open Label ◽  
Open Label Trial

A multicenter, open-label trial of talimogene laherparepvec (T-VEC) plus pembrolizumab vs pembrolizumab monotherapy in previously untreated, unresected, stage IIIB-IV melanoma.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. TPS9081-TPS9081 ◽  
Author(s):  
Antoni Ribas ◽  
Igor Puzanov ◽  
Thomas Gajewski ◽  
Georgina V. Long ◽  
Reinhard Dummer ◽  
...  
Keyword(s):  
Stage Iiib ◽  
Talimogene Laherparepvec ◽  
Open Label ◽  
Open Label Trial
Sign in / Sign up

Export Citation Format

Share Document